Insulin lispro is a rapid-acting insulin analog to regular insulin. Inversion of the proline-lysine amino acid sequence at positions 28 and 29 on the B chain is responsible for its more rapid absorption, faster onset, and shorter duration of action compared with regular insulin. The fast ...
insulin lis·pro (lĭs′prō′) n. A rapid-acting insulin analog whose amino acid sequence differs from that of human insulin by a reversal in the order of lysine and proline in the B chain, used in the treatment of type 1 and type 2 diabetes. [Alteration of lys(ine) + pro(line...
;long-acting —insulina de acción prolongada;NPH —insulina NPH;pre-mixed —insulina premezclada;rapid-acting —insulina de acción rápida;rapid-acting — analogueanálogo de insulina de acción rápida;recombinant —insulina recombinante;regular —insulina regular;to take —inyectarse insulina...
ADMELOG, a rapid-acting human insulin analog, demonstrated comparable structure, pharmacology, efficacy, and dosing to Humalog. See Important Safety Information
Inhaled insulin: Exubera. (eg, glargine) with a regimen of premeal subcutaneous rapid-acting insulin analog (eg, lispro or aspart) plus a basal long-acting insulin analog (eg,... Odegard,S P. - 《Annals of Pharmacotherapy》 被引量: 47发表: 2005年 加载更多来源...
Learn about Humalog®, a fast-acting mealtime insulin used to treat people with diabetes for the control of high blood sugar
Learn about Humalog®, a fast-acting mealtime insulin used to treat people with diabetes for the control of high blood sugar
Rapid-acting insulin analogues such as insulin lispro and insulin aspart produce a more physiological profile of insulin activity than does conventional re... DP Roach,JR Woodworth - 《Clinical Pharmacokinetics》 被引量: 148发表: 2002年 胰岛素类型的研究进展 目前有300多个胰岛素类似物已在实验室制备出...
The U.S. Food and Drug Administration (FDA) has approved Lyumjev (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's new rapid-acting insulin indicated to improve glycemic control in adults with type 1 diabetes and ty
Admelog (insulinlispro injection) is a rapid-acting human insulinanalogindicated to improve glycemic control in adults and pediatric patients 3 years and older withtype 1 diabetesmellitus and adults withtype 2 diabetesmellitus. What Are Side Effects of Admelog?